Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illumisoft Lighting is a Canadian lighting and environmental health technology company that develops commercial LED lighting products and UV-based air disinfection systems for occupied indoor spaces. Its portfolio includes high-efficiency diffused LED fixtures for offices, healthcare facilities, schools, and government buildings, as well as the Sanilume upper-room germicidal UVC system for reducing airborne pathogen burden. The company positions its technology around improving indoor environmental quality through energy-efficient illumination and infection prevention. Illumisoft became publicly traded on the TSX Venture Exchange in April 2026 under the symbol UVC following a qualifying transaction. Although it has healthcare-related applications, it is not a traditional biotech or pharmaceutical developer and does not appear to operate a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Illumisoft Lighting.